[144] Disc Medicine, Inc. SEC Filing

Rhea-AI Filing Summary

Bel Fuse Inc. (Nasdaq: BELFB) filed a Form 8-K dated 24 Jul 2025.

• Item 2.02 – Results of Operations: the Company furnished a press release covering financial results for the three- and six-month periods ended 30 Jun 2025. The release is included as Exhibit 99.1 but the filing itself does not reproduce any revenue, earnings or guidance figures.
• Item 5.05 – Code of Ethics update: on 23 Jul 2025 the Board, acting on the Audit Committee’s recommendation, adopted amendments to the Company’s Code of Ethics. Revisions mainly clarify requirements for compliance with applicable laws, rules, regulations and internal policies. The amended Code is filed as Exhibit 14.1 and will be posted in the Investor section of the Company’s website.

No other material events, transactions or financial statements were disclosed. Accordingly, investor impact is limited to governance enhancements and the forthcoming review of Q2 results once Exhibit 99.1 is consulted.

Positive

• Governance strengthened: Board-approved amendments to the Code of Ethics clarify compliance expectations for all employees, reducing potential regulatory risk.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Minor governance enhancement; financial impact neutral until Q2 figures reviewed.

The 8-K’s only actionable item is the Board’s adoption of a clarified Code of Ethics, a routine yet positive governance measure that reduces compliance risk. The absence of embedded financial data means investors must consult Exhibit 99.1 for performance evaluation. Because the ethics update carries no direct earnings effect and financial specifics are unavailable, the filing is neutral from a valuation standpoint.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch One Bryant Park New York NY 10036	13033	794231.02	34634295	07/24/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/01/2020	Private Placement	Issuer			13033	05/01/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Atlas Venture Fund X, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common Stock	07/18/2025	1184	72375.20
Atlas Venture Opportunity Fund I, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common Stock	07/18/2025	664	40588.80
Atlas Venture Fund X, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common Stock	07/23/2025	53215	3244656.91
Atlas Venture Opportunity Fund I, LP. 300 Technology Sq Ste 8 Cambridge MA 02139	Common Stock	07/23/2025	29837	1819239.47

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Bel Fuse (BELFB) disclose in its July 24 2025 Form 8-K?

The filing reports a Q2 2025 results press release (Exhibit 99.1) and Board-approved amendments to the Company’s Code of Ethics (Exhibit 14.1).

Did Bel Fuse update its Code of Ethics in 2025?

Yes. On 23 Jul 2025 the Board adopted an amended Code clarifying compliance with laws, rules and Company policies.

Where can investors find Bel Fuse’s amended Code of Ethics?

The full text is filed as Exhibit 14.1 and will be posted on belfuse.com under the Investors → Corporate Governance section.

Are Bel Fuse’s Q2 2025 financial numbers included in the 8-K text?

No. The figures are contained in the press release furnished as Exhibit 99.1; they are not reproduced within the filing body.